Statins attenuate polymethylmethacrylate-mediated monocyte activation

Acta Orthopaedica

Volumn 79, Issue 1, 2008, Pages 134-140

  Laing, Alan J ^a   Dillon, John P ^a   Mulhall, Kevin J ^a   Wang, J H ^a   McGuinness, Anthony J ^a   Redmond, Paul H ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLY(METHYL METHACRYLATE); RAF PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UO 126;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IN VITRO STUDY; MONOCYTE; OSTEOLYSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; ARTHROPLASTY, REPLACEMENT; CYTOKINES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MODELS, BIOLOGICAL; MONOCYTES; OSTEOLYSIS; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; PYRIDINES;

EID: 39449135402     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710014888     Document Type: Article

References (34)

1. Abbas S, Clohisy JC, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 2003; 21 (6):1041-8.
2. Algan S M, Purdon M, Horowitz S M. Role of tumor necrosis factor alpha in particulate - induced bone resorption. J Orthop Res 1996; 14: 30-5.
3. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000; 294 (3): 1043-6.
4. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Nonlipid-related effects of statins. Ann Med 2000; 32 (3): 164-76.
5. Blain T A, Pollice P F, Rosier R N, Reynolds P R, Puzas J E, O'Keefe R J. Modulation of the production of cytokines in titanium- stimulated human peripheral blood monocytes by pharmacological agents. The role of cAMP-mediated signaling mechanisms. J Bone Joint Surg (Am) 1997; 79: 1519-28.
6. Catelas I, Huk O L, Petit A, Zukor D J, Marchand R, Yahia L. Flow cytometric analysis of macrophage response to polymethylmetacrylate particle debris: effect of size, morphology and surface area. J Biomed. Mater Res 1998; 41: 600-7.
7. Childs L M, Goater J J, O'Keefe R J, Schwartz E M. Effect of anti-tumor necrosis factor?α gene therapy on wear debris-induced osteolysis. J. Bone Joint Surg (Am) 2001a; 83: 1790-7.
8. Childs L M, Goater J J, O'Keefe R J, Schwartz E M. Efficacy of etanercept for wear debris-induced osteolysis. J. Bone Miner Res 2001b; 16: 338-47.
9. Favata M F, Horiuchi K Y, Manos E J, Daulerio A J, Stradley D A, Feeser W S, Van Dyk D E, Pitts W J, Earl R A, Hobbs F, Copeland R A, Magolda R L, Scherle P A, Trzaskos J M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273 (29):18623-32.
10. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000; 36 (2): 427-31.
11. Frokjaer J, Deleuran B, Lind M, Overgaard S, Soballe K, Bunger C. Polyethylene particles stimulate monocyte chemotactic and activating factor production in synovial mononuclear cells in vivo. An immunohistochemical study in rabbits. Acta Orthop Scand 1995; 66: 303-7.
12. Glant T T, Jacobs J J, Molnar G, Shanbhag A S, Valyon M, Galante J O. Bone resorption activity of particulate-stimulated macrophages. J Bone Min Res 1993; 8: 1071-9.
13. Hilgendorff A, Muth H, Parviz B, Staubitz A, Haberbosch W, Tillmanns H, Holschermann H. Statins differ in their ability to block NF-kappaB activation in human blood monocytes. Int J Clin Pharmacol Ther 2003; 41 (9): 397-401.
14. Horowitz S M, Purdon M A. Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants. Calcif Tissue Int 1995; 57: 301-5.
15. Horowitz S M, Doty S B, Lane J M, Burstein A H. Studies of the mechanism by which the mechanical failure of polmethylmethacrylate leads to bone resorption. J Bone Joint Surg( Am) 1993; 75: 802-13.
16. Horowitz S M, Doty S B, Rapuano B P, Lane J M, Burstein A H. Role of the macrophage and the osteoblast in aseptic loosening. Calcific Tissue Int 1994; 54: 320-4.
17. Kim K J, Kotake S, Udagawa N, Ida H, Ishii M, Takei I, Kubo T, Takagi M. Osteoprotegerin inhibits invitro mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty J Biomed Mater Res 2001; 58 (4): 393-400.
18. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin T J, Suda T. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000; 191: 275-86.
19. Mandelin J, Li T F, Lihjestrom M, Kroom M E, Hanemaaijer R, Santavirta S, Konttinen Y T. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg (Br) 2003; 85 (8): 1196-201.
20. Millett P J, Allen M J, Bostrom M P. Effects of alendronate on particle induced osteolysis in a rat model. J Bone Joint Surg (Am) 2002; 84 (2): 236-49.
21. Mulhall K J ,Curtin W A, Given F H. Inhibition of polymethylmethacrylate particle induced monocyte activation and IL-1β and TNFα expression by the antioxidant agent N-acetlycysteine. Acta Orthop Scand 2002; 73 (2): 206-12.
22. Nakashima Y, Sun D-H, Trindade M C D, Chun L E, Song Y, Goodman S B, Schurman D J, Maloney W J, Smith R L. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg (Br) 1999; 81: 155-62.
23. Ortego M, Bustos C, Hernandez-Presa M A, Tunon J, Diaz C, Hernandez G, Egido J. Atorvastatin reduces NFkappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 1999; 147 (2): 253-61.
24. Roebuck K A, Jacobs J J, Glant T T. New Horizons in Orthopaedic Research: cellular signal transduction pathways J Bone Joint Surg (Am)1999; 81: 599-602.
25. Schmalzried T P, Akizuki K H, Fedenko A N, Mirra J. The role of access of joint fluid to bone in periarticular osteolysis. A report of four cases. J Bone Joint Surg (Am) 1997; 79: 447-52.
26. Schwarz E M, Looney R J, O'Keefe R J. Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res 2000; 2 (3): 165-8.
27. Shanbhag A S, Jacobs J J, Black J, Galante J O, Glant T T. Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 1995; 13: 792-801.
28. Shanbhag A S, Hasselman C T, Rubash H E. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 1997; (344): 33-43.
29. Stancu C, Sima A. Statins: Mechanism of action and effects. J Cell Mol Med 2001; 5 (4): 378-87.
30. Takagi M, Santavirta S, Ida H, Ishii M, Mandelin J, Konttinen Y T. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints. Clin Orthop 1998; (352): 35-45.
31. Ulrich-Vinther M, Carmody E E, Goater J J, Søballe K, O'Keefe R J, Schwarz E M. Recombinant adeno- associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg (Am) 2002; 84 (8): 1405-12.
32. Vaughan C J. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol 2003; 91 (4A):23B-29B.
33. Vaughan C J, Gotto A M Jr, Basson C T. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 2000; 35 (1): 1-10.
34. Willert H-G, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977; 11: 157-64.